Idris, I. (2024). The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH). Wiley. https://doi.org/10.1002/doi2.92
Chicago Style (17th ed.) CitationIdris, Iskandar. The US Food and Drug Administration Has Approved Resmetirom as the First Drug to Treat Metabolic Dysfunction‐associated Steatohepatitis (MASH). Wiley, 2024. https://doi.org/10.1002/doi2.92.
MLA (9th ed.) CitationIdris, Iskandar. The US Food and Drug Administration Has Approved Resmetirom as the First Drug to Treat Metabolic Dysfunction‐associated Steatohepatitis (MASH). Wiley, 2024. https://doi.org/10.1002/doi2.92.
Warning: These citations may not always be 100% accurate.